Clinical
Trials
Finder
Conditions
Locations
Search Trials
Search
Menu
Conditions
Locations
Search Trials
Data sourced from ClinicalTrials.gov
Conditions
Diffuse Large B Cell Lymphoma
New Delhi, National Capital Territory of Delhi
Diffuse Large B Cell Lymphoma Clinical Trials in New Delhi, National Capital Territory of Delhi
1 recruiting
New Delhi, National Capital Territory of Delhi, India
Showing
1–1
of
1
trials
Recruiting
Phase 2
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Diffuse Large B Cell Lymphoma
Karyopharm Therapeutics Inc
244 enrolled
176 locations
NCT02227251
Feedback